Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,810 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03450512Recruiting
Study of bowel inflammation in adults with AML on intensive treatment
This study looks at how often a serious bowel problem (neutropenic enterocolitis) happens in adults with acute myeloid leukemia (AML) during intensive chemotherapy that lowers infection-fighting cells. The results may help doctors monitor and prevent complications during treatment.
AmiensAges 18 years+ - NCT03516617RecruitingPhase 2
Acalabrutinib with or without obinutuzumab for early CLL/SLL
This Phase 2 trial studies whether acalabrutinib, and optionally adding obinutuzumab, can control early-stage chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It aims to see how well these treatments work and how safe they are in people who have not had prior treatment.
Scottsdale, ArizonaAges 18 years+ - NCT03649581Recruiting
Brain-scan study in catatonia and hebephrenia with stable schizophrenia
This study measures brain signals during scans to look for patterns linked to two types (subforms) of psychotic disorders. If you have schizophrenia or schizoaffective disorder and your symptoms have been stable, you may be able to help researchers understand these brain markers.
StrasbourgAges 18–65 - NCT03729180Recruiting
Using genetic test results to guide care during surgery
This study looks at whether using a person’s genetic information helps doctors make better decisions during planned surgery. It may help tailor care, but you would only join if you can consent and don’t have certain serious conditions.
Chicago, IllinoisAges 18 years+ - NCT03892993Recruiting
Decision aid for medullary thyroid cancer treatment choices
This study tests a patient-and-caregiver decision guide to help you decide when to start or stop a new cancer drug, join a clinical trial, or continue active surveillance. It aims to make tough choices feel clearer and more supported.
Houston, TexasAges 18 years+ - NCT03951467Recruiting
Health literacy support to help you follow medical advice
This study tests whether a communication tool matched to your health literacy level can improve how well people follow medical recommendations after an acute episode. It may help you understand your care plan and take the right next steps at home.
BronAges 18 years+ - NCT03987308Recruiting
Test shot medicine versus insulin pump for new type 2 diabetes
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
Beijing, Beijing MunicipalityAges 18–70 - NCT04001582Recruiting
UK facial and shoulder muscle disease patient registry
This registry aims to collect health information from people in the UK who have facioscapulohumeral muscular dystrophy (FSHD). It helps researchers better understand the disease and plan future studies.
Newcastle upon TyneAges Any age - NCT04003038Recruiting
Negative pressure wound dressings after breast reconstruction in obesity
This trial tests whether a special “suction” dressing (negative pressure wound therapy) helps wounds heal better after breast reconstruction using tissue from the belly, especially in people with higher body weight. You may be more likely to benefit if you’re at higher risk for wound problems after abdominal flap surgery.
Houston, TexasAges 18 years+ - NCT03847649RecruitingPhase 2
Durvalumab for cancer after stopping immune therapy due to side effects
This Phase 2 trial tests whether durvalumab (an immunotherapy) can still help treat advanced cancer after you had to stop an earlier immune checkpoint medicine because of immune-related side effects. If you’re already on a durvalumab-based study, Substudy B also looks at continuing durvalumab (with or without tremelimumab) when it’s safe for you.
Edmonton, AlbertaAges 18 years+ - NCT06814626RecruitingPhase 3
Nutrition therapy for muscle loss in cirrhosis with fluid buildup
This trial tests whether a special nutrition plan can help treat muscle loss in people with liver cirrhosis who also have fluid buildup that doesn't improve with standard treatment. It aims to improve strength and outcomes after a procedure to place a shunt in the liver.
PalermoAges 18–80 - NCT06755710Recruiting
Patient engagement study for PTSD treatment
This trial tests whether a program that helps people actively take part in their PTSD treatment leads to better outcomes. It is designed for adults with PTSD, including refugees, and aims to improve treatment engagement and results.
Ballerup Municipality, Capital RegionAges 18 years+ - NCT04080635Recruiting
Check how to monitor brodalumab blood levels in psoriasis
This study measures brodalumab levels in your blood to see whether “therapeutic drug monitoring” can guide treatment in people with plaque psoriasis. If you’re eligible, it may help doctors better match the medicine to your body.
Ghent, Oost-VlaanderenAges 18 years+ - NCT04139850Recruiting
Study of adults with chronic hepatitis B in Korea
This study follows adults with long-term hepatitis B to better understand their health over time and improve care. If you have chronic hepatitis B and can do regular check-ins, you may be invited to join.
SeoulAges 19 years+ - NCT04183608RecruitingPhase 4
Telemonitoring and education to guide treatment for ulcerative colitis
This trial tests whether “treat-to-target” care—guided by regular symptom checks, telemonitoring, and patient education—works better than standard follow-up when starting adalimumab for ulcerative colitis. It aims to help control inflammation more effectively and reduce flare-ups.
Cholet, Maine Et LoireAges 18–75 - NCT04207580Recruiting
Follow-up study for children with newly diagnosed nephrotic syndrome
This study follows children in France who developed idiopathic nephrotic syndrome after 2018, to learn how the condition behaves over time. It may help doctors improve future care by tracking symptoms and outcomes.
AgenAges Up to 18 years - NCT04215211Recruiting
AI tool to predict survival in people with glioma
This trial uses brain scan images (MRI) and tumor tissue tests to predict how long people with primary glioma may live. The goal is to see if the AI prediction can improve planning and care after surgery.
Zhengzhou, HenanAges 1–90 - NCT04215224Recruiting
AI prediction of outcomes for glioma after tumor surgery
This trial uses AI to look at tumor tissue images to predict survival in people with glioma. If you qualify, your surgery tissue and imaging help train tools that may better estimate outcomes and guide care.
Zhengzhou, HenanAges 1–90 - NCT04215731RecruitingPhase 3
Chemo plus targeted drug before surgery for high-risk rectal cancer
This trial tests giving chemotherapy (mFOLFOXIRI) plus bevacizumab before surgery for rectal cancer that has higher-risk features. It aims to shrink or control the cancer early to improve outcomes after treatment.
Guangzhou, GuangdongAges 18–70 - NCT04253015Recruiting
Safety registry for people with high-risk neuroblastoma on dinutuximab beta
This study is a long-term safety and follow-up registry. It tracks how dinutuximab beta is doing in real-world patients with high-risk neuroblastoma over time.
Vienna, State of ViennaAges 1–18 - NCT04345081Recruiting
Compare two breast surgery skin-sparing methods and recovery
This trial compares two types of mastectomy (with skin and nipple options) and implant reconstruction to see which gives better cosmetic results, comfort, and satisfaction. You may help doctors learn which approach leads to a better quality of life after surgery.
BudapestAges 18–65 - NCT04349527Recruiting
Comparing breast-conserving surgeries and how you feel after
This trial compares two breast-conserving surgery techniques to see how they affect cosmetic results (how the breast looks), quality of life, and patient satisfaction. It may help guide the best surgical approach for people eligible for breast conservation.
BudapestAges 18–65 - NCT04356209RecruitingPhase 2
Pravastatin for severe radiation breast scar tissue, with e-reports
This trial tests whether pravastatin can improve severe radiation-related breast scarring and breast-related quality of life. It also studies whether using an electronic patient questionnaire (e-PRO) helps patients’ outcomes and support during treatment.
MontpellierAges 18 years+ - NCT04389463Recruiting
Study of heart surgery outcomes during COVID-19
This study looks at how people do after heart or chest surgery when they test positive for COVID-19. It may help doctors understand risks and outcomes for surgical patients during the pandemic.
NantesAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,810 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.